-
World Breast Cancer Awareness Month | Renowned Physicians’ Protection, Building a Healthy Future Together —— Focusing on Breast Cancer Prevention and Treatment (2)
Professor Guangyu Liu（Fudan University Shanghai Cancer Center）： Breast cancer is a major threat to women’s health globally and is increasingly drawing widespread attention from all sectors of society. As we…
-
Professor Yehui Shi: The Epigenetic Regulation of HR+ Metastatic Breast Cancer—A Review of the Development Path of HDACi Entinostat
Histone deacetylases (HDACs) are histone-modifying enzymes that regulate epigenetic changes. They control the acetylation process of histone post-translational modifications by removing the N-acetyl group from acetylated lysine residues in histones…
-
National Healthy Lifestyle Promotion Month | Focusing on Breast Health: Authoritative Experts Discuss Breast Cancer Prevention and Treatment — Part I
Professor Jianyun NieYunnan Cancer Hospital With the continuous progress of medicine, curing breast cancer is gradually becoming possible. We once again call on breast cancer patients to face the disease…
-
National Healthy Lifestyle Promotion Month | Focusing on Breast Health: Authoritative Experts Discuss Breast Cancer Prevention and Treatment — Part2
Professor Zhimin FanThe First Hospital of Jilin University The global incidence of breast cancer is rising year by year. However, with the implementation of standardized and normalized treatments, mortality rates…
-
The Journal of Hepatology: A New Era Begins at 40
As the Journal of Hepatology marks its 40th anniversary, Vlad Ratziu leads a new editorial team, carrying forward the journal’s legacy of excellence. Over the past two decades, the journal…
-
ASH 2024 | Dr. Minghui Duan: Exploring the Combination of Selinexor and Ruxolitinib in Myelofibrosis Treatment
From December 7 to 10, 2024, the 66th American Society of Hematology (ASH) Annual Meeting took place in San Diego, USA, bringing together global experts to discuss the latest advancements in hematology. During this prestigious event, Dr. Minghui Duan from Peking Union Medical College Hospital presented his team’s latest findings on myelofibrosis (MF) treatment (Abstract…
-
ASH 2024 | Professor Jerald Radich：Mutations and Minimal Residual Disease (MRD): Clinical Implications of Clonal Origins
Minimal residual disease (MRD) is a powerful predictor of relapse in acute myeloid leukemia (AML), yet its accuracy remains a challenge. Some patients who are MRD-positive do not relapse, while others who are MRD-negative still experience disease recurrence. At the 2024 American Society of Hematology (ASH) Annual Meeting, Professor Jerald Radich from Fred Hutchinson Cancer…
Connecting Medical Expertise through Media
